John Houghton

647 total citations
26 papers, 389 citations indexed

About

John Houghton is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, John Houghton has authored 26 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Oncology and 7 papers in Genetics. Recurrent topics in John Houghton's work include Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Iron Metabolism and Disorders (3 papers). John Houghton is often cited by papers focused on Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Iron Metabolism and Disorders (3 papers). John Houghton collaborates with scholars based in United Kingdom, United States and Sweden. John Houghton's co-authors include Martin Rowlands, Dónal O’Donoghue, Raymond McCague, S. Elaine Barrie, Richard Feltbower, C. R. Stephenson, H. J. Bodansky, David Haigh, P A McKinney and Roy Reeve and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and American Journal of Kidney Diseases.

In The Last Decade

John Houghton

25 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Houghton United Kingdom 10 109 83 75 74 53 26 389
Andrew Saunders United Kingdom 10 46 0.4× 109 1.3× 110 1.5× 39 0.5× 115 2.2× 24 464
Gaurav Tripathi India 13 39 0.4× 37 0.4× 64 0.9× 39 0.5× 29 0.5× 37 369
Hisaki Shimada Japan 11 77 0.7× 54 0.7× 278 3.7× 26 0.4× 85 1.6× 19 471
Insa E. Emrich Germany 14 44 0.4× 71 0.9× 269 3.6× 58 0.8× 131 2.5× 42 616
J Sobota United States 9 146 1.3× 26 0.3× 140 1.9× 39 0.5× 132 2.5× 21 556
Tetsuhei Ogawa Japan 10 53 0.5× 217 2.6× 31 0.4× 33 0.4× 116 2.2× 35 654
Hideki Yamaya Japan 12 266 2.4× 63 0.8× 158 2.1× 15 0.2× 41 0.8× 28 625
C.J. Olbricht Germany 10 47 0.4× 71 0.9× 74 1.0× 20 0.3× 256 4.8× 20 503
Juanwen Zhang China 12 34 0.3× 103 1.2× 37 0.5× 17 0.2× 92 1.7× 25 503
S. Schauseil Germany 8 87 0.8× 57 0.7× 18 0.2× 21 0.3× 88 1.7× 10 366

Countries citing papers authored by John Houghton

Since Specialization
Citations

This map shows the geographic impact of John Houghton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Houghton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Houghton more than expected).

Fields of papers citing papers by John Houghton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Houghton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Houghton. The network helps show where John Houghton may publish in the future.

Co-authorship network of co-authors of John Houghton

This figure shows the co-authorship network connecting the top 25 collaborators of John Houghton. A scholar is included among the top collaborators of John Houghton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Houghton. John Houghton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Osman, Faizel, Belinda Sandler, Florence Brellier, et al.. (2025). Treatment Patterns, Outcomes and Healthcare Resource Utilization of Obstructive Hypertrophic Cardiomyopathy in England. ESC Heart Failure. 12(3). 2034–2046.
3.
Choy, Ernest, et al.. (2021). Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study. BMC Rheumatology. 5(1). 3–3. 6 indexed citations
4.
Provenzano, Robert, Steven Fishbane, Pablo E. Pérgola, et al.. (2021). POS-284 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN POOLED PHASE 3 TRIALS OF ROXADUSTAT IN DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE. Kidney International Reports. 6(4). S121–S121. 1 indexed citations
5.
Provenzano, Robert, Lynda A. Szczech, Robert Leong, et al.. (2021). Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD. Clinical Journal of the American Society of Nephrology. 16(8). 1190–1200. 56 indexed citations
6.
New, John P., Theingi Aung, Paul Baker, et al.. (2008). The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population‐based study. Diabetic Medicine. 25(5). 564–569. 60 indexed citations
7.
Tholouli, Eleni, Matthew Krebs, Roy Reeve, & John Houghton. (2005). Crystal‐storing histiocytosis in a patient with IgGκ multiple myeloma. British Journal of Haematology. 128(4). 412–412. 12 indexed citations
8.
Wong, CL, et al.. (2003). Papuloerythroderma of Ofuji associated with acute myeloid leukaemia. Clinical and Experimental Dermatology. 28(3). 277–279. 6 indexed citations
9.
Feltbower, Richard, H. J. Bodansky, P A McKinney, et al.. (2002). Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabetic Medicine. 19(2). 162–166. 45 indexed citations
10.
O’Riordan, Edmond, Roy Reeve, John Houghton, Dónal O’Donoghue, & S. Waldek. (2001). Primary bilateral T‐cell renal lymphoma presenting with sudden loss of renal function. Nephrology Dialysis Transplantation. 16(7). 1487–1489. 20 indexed citations
11.
Newland, Adrian C., Jamie Cavenagh, A. Copplestone, et al.. (2001). Vigam‐S, a solvent/detergent‐treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura. Transfusion Medicine. 11(1). 37–44. 15 indexed citations
12.
Macheta, Mac, et al.. (2001). Prominent dyserythropoiesis in four cases of haemophagocytic lymphohistiocytosis. Journal of Clinical Pathology. 54(12). 961–963. 6 indexed citations
13.
Jarman, Michael, et al.. (1994). Evaluation of Some 4-Fluoro-and 4-Cyano Derivatives of δ4, 3-Ketosteroids as Inhibitors of Testosterone 5α-Reductase. Journal of enzyme inhibition. 8(1). 17–23. 1 indexed citations
14.
McCague, Raymond, Martin Rowlands, S. Elaine Barrie, & John Houghton. (1990). Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid. Journal of Medicinal Chemistry. 33(11). 3050–3055. 52 indexed citations
15.
Houghton, John, et al.. (1988). 1-alkyl analogues of aminoglutethimide. Biochemical Pharmacology. 37(11). 2167–2172. 3 indexed citations
16.
Parr, Iris B., Martin Rowlands, John Houghton, & Michael Jarman. (1988). Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproate. Biochemical Pharmacology. 37(23). 4581–4583. 3 indexed citations
18.
Houghton, John, et al.. (1987). The inhibitory effect of p-trifluoromethyl substitution on the hepatic microsomal metabolism of benzyl phenyl sulphide. Biochemical Pharmacology. 36(3). 400–403. 1 indexed citations
19.
Houghton, John. (1979). Neutrophil function and diagnosis of pre-leukaemic states. Postgraduate Medical Journal. 55(644). 396–399. 5 indexed citations
20.
Houghton, John & P J Toghill. (1978). Myasthenia gravis and red cell aplasia.. BMJ. 2(6149). 1402.2–1403. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026